List of SBIR/STTR awards granted to Apogee Biotechnology

where

SBIR/STTR Award Recipient

‌

Apogee Biotechnology

Name	Description	SBIR/STTR Award Recipient	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ Apogee Biotechnology Corporation SBIR Phase I Award, August 2019	A SBIR Phase I contract was awarded to Apogee Biotechnology in August, 2019 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Apogee Biotechnology	National Institutes of Health	SBIR	1R43CA235804-01A1	Phase I	225,000	August 1, 2019	sbir.gov/node/1683219
‌ Apogee Biotechnology Corporation SBIR Phase I Award, July 2015	A SBIR Phase I contract was awarded to Apogee Biotechnology in July, 2015 for $225,000.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43CA192414-01A1	Phase I	225,000	July 1, 2015	sbir.gov/node/1029705
‌ Apogee Biotechnology Corporation SBIR Phase II Award, September 2015	A SBIR Phase II contract was awarded to Apogee Biotechnology in September, 2015 for $1,979,746.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R44CA199767-01	Phase II	1,979,746	September 1, 2015	sbir.gov/node/1046827
‌ Apogee Biotechnology Corporation STTR Phase II Award, September 2014	A STTR Phase II contract was awarded to Apogee Biotechnology in September, 2014 for $1,141,551.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		STTR	2R42CA183708-03A1	Phase II	1,141,551	September 17, 2014	sbir.gov/node/1028543
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $100,000.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43AR052261-01	Phase I	100,000		sbir.gov/content/sphingosine-kinase-inhibitors-anti-arthritis-agents-0
‌ Apogee Biotechnology Corporation SBIR Phase II Award,	A SBIR Phase II contract was awarded to Apogee Biotechnology for $996,642.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	2R44AR052261-02A1	Phase II	996,642		sbir.gov/content/sphingosine-kinase-inhibitors-anti-arthritis-agents-2
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $593,448.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43AI098309-01A1	Phase I	593,448		sbir.gov/node/677458
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $219,476.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43HL083765-01A1	Phase I	219,476		sbir.gov/content/anti-atherosclerosis-agents-targeting-sphingosine-kinase-0
‌ Apogee Biotechnology Corporation SBIR Phase II Award,	A SBIR Phase II contract was awarded to Apogee Biotechnology for $1,694,410.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	2R44DK071395-02	Phase II	1,694,410		sbir.gov/content/sphingosine-kinase-inhibitors-anti-ibd-agents-2
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $129,250.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43EY016608-01	Phase I	129,250		sbir.gov/content/sphingosine-kinase-inhibitors-diabetic-retinopathy-0
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $492,349.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43CA102853-01	Phase I	492,349		sbir.gov/content/novel-inhibitors-human-n-myristoyltransferase-0
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $316,916.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43DK096685-01	Phase I	316,916		sbir.gov/node/400242
‌ Apogee Biotechnology Corporation STTR Phase I Award,	A STTR Phase I contract was awarded to Apogee Biotechnology for $600,000.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		STTR	1R41AI087167-01A1	Phase I	600,000		sbir.gov/node/378304
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $100,011.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43AI051902-01	Phase I	100,011		sbir.gov/content/improved-anti-hiv-therapy-p-glycoprotein-inhibitors-0
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $473,108.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43CA097833-01A2	Phase I	473,108		sbir.gov/content/novel-inhibitors-sphingosine-kinase-0
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $491,543.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43CA096073-01	Phase I	491,543		sbir.gov/content/novel-azabicyclooctane-inhibitors-p-glycoprotein-0
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $647,461.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43CA110071-01	Phase I	647,461		sbir.gov/content/inhibitors-human-pal-mitoyl-acyltransferase-0
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $176,603.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43DK071395-01A1	Phase I	176,603		sbir.gov/content/sphingosine-kinase-inhibitors-anti-ibd-agents-0
‌ Apogee Biotechnology Corporation SBIR Phase I Award,	A SBIR Phase I contract was awarded to Apogee Biotechnology for $224,116.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	1R43DK101146-01	Phase I	224,116		sbir.gov/node/705579
‌ Apogee Biotechnology Corporation STTR Phase I Award,	A STTR Phase I contract was awarded to Apogee Biotechnology for $260,988.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		STTR	1R41CA132413-01A2	Phase I	260,988		sbir.gov/content/optimization-dipeptide-linked-benzimidazole-topoisomerase-1-poisons-0
‌ Apogee Biotechnology Corporation SBIR Phase II Award,	A SBIR Phase II contract was awarded to Apogee Biotechnology for $953,134.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		SBIR	2R44EY016608-02	Phase II	953,134		sbir.gov/content/sphingosine-kinase-inhibitors-anti-retinopathy-agents-0
‌ Apogee Biotechnology Corporation STTR Phase I Award,	A STTR Phase I contract was awarded to Apogee Biotechnology for $526,907.0 USD from the U.S. Department of Health & Human Services.	‌ Apogee Biotechnology		STTR	1R41DK084632-01	Phase I	526,907		sbir.gov/content/improvement-liver-transplantation-sphingosine-kinase-inhibitor-0
‌ Apogee Biotechnology Corporation SBIR Phase II Award, August 2023	A SBIR Phase II contract was awarded to Apogee Biotechnology in August, 2023 for $852,174.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Apogee Biotechnology	National Institutes of Health	SBIR	1R44AI179348-01	Phase II	852,174	August 1, 2023	sbir.gov/node/2511187

23 results

0 selected

23 results

0 selected